Microsoft buys genetic data software from Merck
Wall Street Journal, June 3, 2009
Microsoft continued its push into healthcare through a deal with Merck to gain access to some genetic data-management software. Microsoft plans to incorporate the genetic and genomic data-management software into Microsoft Amalga Life Sciences. Amalga is part of a push by Microsoft, whose other offerings include patient health-records holder HealthVault, to become a bigger player in healthcare.
- Providers' Push to Consolidate Roils Payers
- As Retail Clinics Surge, Quality Metrics MIA
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- RN Named Chief Patient Experience Officer
- Medicare Cost, Quality Data Tools Weak, Says GAO
- No Employee Satisfaction, No Patient-Centered Culture
- In PCMH, the 'P' is Not for 'Physician'
- Population Health Pays Off for NY Collaborative
- Six Not-So-Good Reasons for Avoiding Population Health
- How Simple Data Analytics is Driving Physician Incentives